1.	Phase III Study of Radiotherapy and Amifostine OR Neoadjuvant Induction Chemotherapy Followed By Consolidation Chemoradiotherapy and Amifostine in Children With Newly Diagnosed Nasopharyngeal Carcinoma Phase: Phase III Type: Treatment Status: Active Age: 18 and under Sponsor: NCI Protocol IDs: COG-ARAR0331, ARAR0331, NCT00274937
2.	Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: UCIRB #14735B, GV-001.010 (TNF-ELF), NCT00496236
3.	Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 603EUSA03, NCT00901732
4.	Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06U.195, NCT00358007
5.	Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-050, NCT00713219
6.	A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: J0813, 1 R21 CA135635-01, NCT00894413
7.	A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05C.255, NCT00329589
8.	Phase I Randomized Pilot Study of Adjuvant Mutant p53 Peptide-Pulsed Dendritic Cell Vaccine With or Without T-Helper Peptides in Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: PCI-03-156, PCI-0507062, NCT00404339
9.	Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
10.	Phase I Pilot Study of Photodynamic Therapy Comprising HPPH in Patients Undergoing Surgery For Primary or Recurrent Squamous Cell Cancer of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-74606, NCT00470496
11.	Phase I Study of Autologous or Allogeneic LMP-Specific Cytotoxic T-Lymphocytes in Patients With Epstein-Barr Virus (EBV)-Positive Lymphoma, Lymphoepithelioma, or Severe Chronic Active EBV Infection Syndrome Phase: Phase I Type: Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: BCM-H-9936-ALCI, H 9936, NCT00671164
12.	Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HP-41372, UMGCC 0804, NCT00704041
13.	Phase I Pilot Study of Transoral Robotic Surgery Versus Conventional Surgery in Patients With Benign or Malignant Disease Involving the Larynx and Pharynx Phase: Phase I Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: WSU-2008-022, 2008-022, NCT00918762
14.	Erlotinib Prior to Surgery in Patients With Head and Neck Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0137, NCT00954226
15.	Prospective Pilot Study of Functional MRI Mapping and Brain Perfusion Imaging in Patients Undergoing Base of Skull and Brain Radiotherapy for Nonmetastatic Head and Neck Cancer Phase: Phase I Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UPCC-808258, 808258, NCT00984074
16.	Phase I Study of Erlotinib Hydrochloride in Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Premalignant Lesions of the Lung Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 79 Sponsor: NCI Protocol IDs: NU-NWU08-11-01, NWU08-11-01, NCI-08-11-01, RPCI-I-121507, NCT01013831
17.	Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 02-05-127E, NIH-R21-CA104402, NCT00200486
18.	A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy Phase: No phase specified Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 06-1210, NCT00608751
19.	A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-03-080, NCT00627562
20.	STAT3 DECOY in Head and Neck Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCI 07-022, NCT00696176
21.	Photon/Proton Beam Radiation Therapy for Carcinoma of the Nasopharynx Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UFPTI 0605-NP01, NCT00797290
22.	Pilot Study of Catheter-Based Ultrasound Hyperthermia Therapy After Brachytherapy in Patients With Urologic, Gynecologic, or Head and Neck Cancer Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UCSF-08992, 08992, H10778-32056, NCT00911079